Ranlin Yan
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 7
- Cancer Cells and Metastasis 4
- Pancreatic and Hepatic Oncology Research 1
-
- Epigenetics and DNA Methylation 2
- Cancer-related gene regulation 2
- RNA modifications and cancer 2
- Co-authors
- Yingyan Yu (13 shared papers)Zhenggang Zhu (6 shared papers)Zhen Xiang (6 shared papers)Lu Zang (3 shared papers)Wenjun Hu (2 shared papers)Wei Cai (2 shared papers)Jun Ji (1 shared paper)Jun Li (1 shared paper)
- Journals
- Frontiers in Pharmacology (2 papers)International Journal of Biological Sciences (1 paper)Journal of Experimental & Clinical Cancer Research (1 paper)Oncogene (1 paper)Cancer Biology and Medicine (1 paper)
- Partner nations
- ChinaFranceUnited States
In The Last Decade
Ranlin Yan
13 papers receiving 344 citations
Peers
Comparison fields: 5 of 72
- Biological Psychiatry 29
- Oncology 80
- Cancer Research 40
- Immunology 53
- Infectious Diseases 40
Countries citing papers authored by Ranlin Yan
This map shows the geographic impact of Ranlin Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranlin Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranlin Yan more than expected).
Fields of papers citing papers by Ranlin Yan
This network shows the impact of papers produced by Ranlin Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranlin Yan. The network helps show where Ranlin Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ranlin Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 102 | |
| 2 | 2020 | 65 | |
| 3 | 2021 | 63 | |
| 4 | 2018 | 37 | |
| 5 | 2018 | 15 | |
| 6 | 2024 | 14 | |
| 7 | 2023 | 12 | |
| 8 | 2019 | 10 | |
| 9 | 2024 | 10 | |
| 10 | 2021 | 7 | |
| 11 | 2020 | 5 | |
| 12 | 2024 | 3 | |
| 13 | 2023 | 2 |
About Ranlin Yan
Ranlin Yan is a scholar working on Oncology, Molecular Biology, Biological Psychiatry, Immunology and Infectious Diseases, having authored 13 papers that have together received 345 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Epigenetics and DNA Methylation (2 papers), Tryptophan and brain disorders (2 papers), Cancer-related gene regulation (2 papers), RNA modifications and cancer (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Digestive system and related health (1 paper). The work is most often cited by research in Biological Psychiatry (29 citations), Oncology (80 citations), Cancer Research (40 citations), Immunology (53 citations) and Infectious Diseases (40 citations). Ranlin Yan has collaborated with scholars based in China, France and United States. Frequent co-authors include Yingyan Yu, Zhenggang Zhu, Zhen Xiang, Lu Zang, Wenjun Hu, Wei Cai, Jun Ji, Jun Li, Jun Ji and Zhenggang Zhu. Their work appears in journals such as Frontiers in Pharmacology, International Journal of Biological Sciences, Journal of Experimental & Clinical Cancer Research, Oncogene and Cancer Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.